Moderna (NASDAQ: MRNA) stock skyrocketed last year. Its momentum has carried over into 2021 as well. After its tremendous gains, the biotech's market cap is now well over $60 billion. In this Motley Fool Live video recorded on Feb. 3, 2021, Fool.com contributors Keith Speights and Brian Orelli talk about whether Moderna stock is now overvalued after its remarkable run.
Source Fool.com